November 2025
1. OOI H, Asai Y, Kondo Y, Tashiro T, et al
   The Albumin-Bilirubin-Fibrosis-4 Score for Predicting Teicoplanin-Induced Abnormal Liver Enzyme Levels in Patients Undergoing Therapeutic Drug Monitoring: A Multicentral Retrospective Cohort Study.
   Ann Pharmacother. 2025;59:978-988.
   

   >> Share

   
   October 2025
2. OKEKE C, Olateju O, Yunusa I, Bhatt P, et al
   Duration of Concurrent Oxycodone and Selective Serotonin Reuptake Inhibitors Use and the Risk of Opioid Overdose.
   Ann Pharmacother. 2025 Oct 8:10600280251372646. doi: 10.1177/10600280251372646.
   

   >> Share

   
   February 2025
3. OOI H, Asai Y, Koriyama Y, Takahashi M, et al
   Decreased Hepatic Functional Reserve Increases the Risk of Piperacillin/Tazobactam-Induced Abnormal Liver Enzyme Levels: A Retrospective Case-Control Study.
   Ann Pharmacother. 2025;59:117-126.
   

   >> Share

   
   September 2024
4. ESTEVES AM, Buchfellner MC, Holmes BM, Berndsen JA, et al
   Impact of a Divided Phenobarbital Load and Taper Compared With Lorazepam Symptom Triggered Therapy in Hospitalized Patients.
   Ann Pharmacother. 2024;58:896-905.
   

   >> Share

   
   
5. KESSEL KM, Olson LM, Kruse DA, Lyden ER, et al
   Phenobarbital Versus Benzodiazepines for the Treatment of Severe Alcohol Withdrawal.
   Ann Pharmacother. 2024;58:877-885.
   

   >> Share

   
   April 2023
6. WONG A
   Comment: Comparison of 2-Bag Versus 3-Bag N-Acetylcysteine Regimens for Pediatric Acetaminophen Toxicity.
   Ann Pharmacother. 2023;57:505.
   

   >> Share

   
   March 2023
7. DANIEL-MCCALLA SN, Parbuoni KA, Leonard J, Morgan JA, et al
   Medical Outcomes of Acute Aspirin Single Substance Poisoning in Pediatric Patients.
   Ann Pharmacother. 2023 Mar 28:10600280231159898. doi: 10.1177/10600280231159898.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share